The Truth About Methylfolate: Is "Activated Folate" Superior for Fertility and Pregnancy?

For everyone navigating their TTC journey or planning for pregnancy, folate intake is a crucial topic. Many of you may feel overwhelmed or confused by the abundance of information circulating about the difference between "activated folate" (methylfolate) and standard folic acid (pteroylmonoglutamic acid). Your desire to make the best choices for your body and future family is completely understandable.

In this article, as a fertility specialist, I aim to provide calm, objective, and evidence-based insights into methylfolate, folic acid, and their connection to MTHFR gene mutations. It's natural to have questions here. I hope this information serves as a helpful guide in your personalized journey to gather reliable knowledge.

The Fundamental Role of Folate and the Spotlight on "Activated" Forms

Folate, a B vitamin, is essential for cell division and DNA synthesis. During early pregnancy, it plays a vital role in the healthy development of the fetus, particularly the formation of the brain and spinal cord. This is why health authorities worldwide, including the Japanese Ministry of Health, Labour and Welfare, recommend that women planning pregnancy supplement with 400 µg of folic acid daily, in addition to dietary intake.

The folate we consume broadly falls into two categories: synthetic folic acid (pteroylmonoglutamic acid) found in supplements and some fortified foods, and natural polyglutamate folate found in food. Both forms must be converted into their active form, methylfolate, in the body before they can function.

This is where the "MTHFR (methylenetetrahydrofolate reductase) gene mutation" becomes relevant. Individuals with this mutation may have a reduced ability to convert folic acid into its active methylfolate form. Consequently, a debate has emerged: wouldn't it be more efficient for those with MTHFR gene mutations to take methylfolate, which is already in its active form?

MTHFR Gene Mutation and the Evidence for Methylfolate

First, something worth knowing about MTHFR testing itself.

The American College of Medical Genetics and Genomics stated in its 2013 practice guideline that MTHFR polymorphism testing has minimal clinical utility and should not be ordered as a routine test (PMID: 23288205). The reasoning is that the chain once assumed — reduced MTHFR enzyme activity leading to raised homocysteine leading to increased risk of thrombosis and recurrent pregnancy loss — was not supported by subsequent meta-analyses.

In other words, if a conversation begins with "let's test your MTHFR first", the premise of that step is shaky.

This is a practice guideline rather than a trial. What it summarises is that the clinical utility of the test is limited, and that the meta-analyses behind the original rationale did not hold up.

With that established: for people who do carry the variant, there is a discussion about whether methylfolate, already in the usable form, supplies folate more efficiently.

However, for the general healthy adult female population without MTHFR gene mutations, many studies currently show no significant difference in efficacy between standard folic acid and methylfolate. Furthermore, there is no definitive conclusion that methylfolate is "dramatically superior" to standard folic acid for pregnancy rates, outcomes, or birth results, irrespective of MTHFR mutations. The potential benefits of methylfolate tend to be more pronounced in individuals carrying MTHFR gene mutations.

What matters is that the purpose of folate supplementation is to reduce the risk of neural tube defects, and that standard folic acid has been shown to do this. If you are concerned about your MTHFR status, ask your doctor before testing what would change on the basis of the result. Given the guideline position above, it is entirely possible that nothing would.

Understanding the Term "Activated"

While the term "activated" can sound very appealing and suggest superiority over regular folic acid, its effectiveness and necessity must be carefully evaluated based on scientific evidence in a medical context. While methylfolate may offer potential benefits for some individuals, it is not a "magic bullet" for everyone.

The choice of supplement depends on an individual's health status, diet, genetic background, and most importantly, their specific goals. If you're looking for more detailed information on fertility planning, please visit here. To make an optimal choice tailored to your situation, prioritize gathering reliable information and consulting with experts. Feeling uncertain is perfectly normal, and it shows you are committed to understanding your health.

Frequently Asked Questions (FAQ)

Q1: Do I really need methylfolate if I have an MTHFR gene mutation?

A1: Not necessarily. Standard folic acid has been shown to reduce the risk of neural tube defects. More to the point, the ACMG advises against ordering MTHFR polymorphism testing routinely (PMID: 23288205). If the test is suggested to you, a good question is: "will this result change the plan?"

Q2: Are there any special benefits of taking methylfolate supplements?

A2: As methylfolate is already in its active form, it may offer more efficient folate supplementation for individuals with MTHFR gene mutations who have reduced folate metabolism capabilities. However, for the general population, robust evidence definitively showing that methylfolate is superior to standard folic acid in terms of pregnancy rates or outcomes is not yet established. It's important to have a balanced understanding of the information and avoid unrealistic expectations.

Q3: How should I choose a folic acid supplement for my TTC journey?

A3: First, ensure the supplement contains the recommended daily amount of 400 µg of folic acid (pteroylmonoglutamic acid). The choice between methylfolate and standard folic acid can be made based on your individual constitution and your doctor's recommendation. Also, prioritize supplements from reputable manufacturers with reliable quality and production standards. Regardless of the type of folate you choose, consulting with a healthcare provider and selecting a supplement that aligns with your body and goals is most important.

Conclusion

Which supplement to take depends on your health, your diet, and above all on what you are taking it for.

If the purpose is reducing the risk of neural tube defects, standard folic acid at 400 µg has been shown to work. Methylfolate can substitute for it, but it has not been shown to be better. Whether it is worth the higher price is a judgement to make with that in mind — and the test that often precedes the whole discussion is one the ACMG advises against ordering routinely.

Your TTC journey is often a complex path filled with both anxiety and hope. If you have any concerns or doubts about your folate intake, please do not hesitate to consult a fertility specialist. We are here to provide accurate information and support to help you navigate your journey with confidence.

References

Japanese Society of Obstetrics and Gynecology: Guidelines for Obstetric Care 2023.
ACOG Practice Bulletin No.200 (2018): Neural Tube Defects.
Speroff's Clinical Gynecologic Endocrinology and Infertility 9th Ed (Wolters Kluwer 2020).

Written by the same author — a general guide to preconception care and fertility planning: https://www.amazon.com/dp/B0F771VNV5?tag=ttcguide-enblog-22